BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11606583)

  • 1. Alpha(v) integrin, p38 mitogen-activated protein kinase, and urokinase plasminogen activator are functionally linked in invasive breast cancer cells.
    Chen J; Baskerville C; Han Q; Pan ZK; Huang S
    J Biol Chem; 2001 Dec; 276(51):47901-5. PubMed ID: 11606583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rac1-MKK3-p38-MAPKAPK2 pathway promotes urokinase plasminogen activator mRNA stability in invasive breast cancer cells.
    Han Q; Leng J; Bian D; Mahanivong C; Carpenter KA; Pan ZK; Han J; Huang S
    J Biol Chem; 2002 Dec; 277(50):48379-85. PubMed ID: 12377770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteopontin induces AP-1-mediated secretion of urokinase-type plasminogen activator through c-Src-dependent epidermal growth factor receptor transactivation in breast cancer cells.
    Das R; Mahabeleshwar GH; Kundu GC
    J Biol Chem; 2004 Mar; 279(12):11051-64. PubMed ID: 14704150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urokinase plasminogen activator/urokinase-specific surface receptor expression and matrix invasion by breast cancer cells requires constitutive p38alpha mitogen-activated protein kinase activity.
    Huang S; New L; Pan Z; Han J; Nemerow GR
    J Biol Chem; 2000 Apr; 275(16):12266-72. PubMed ID: 10766865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrin β3 and its ligand regulate the expression of uPA through p38 MAPK in breast cancer.
    Wang R; Li ZQ; Han X; Li BL; Mi XY; Sun LM; Song M; Han YC; Zhao Y; Wang EH
    APMIS; 2010 Dec; 118(12):909-17. PubMed ID: 21091771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK).
    Aguirre-Ghiso JA; Estrada Y; Liu D; Ossowski L
    Cancer Res; 2003 Apr; 63(7):1684-95. PubMed ID: 12670923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation by p38 mitogen-activated protein kinase of adenylate- and uridylate-rich element-mediated urokinase-type plasminogen activator (uPA) messenger RNA stability and uPA-dependent in vitro cell invasion.
    Montero L; Nagamine Y
    Cancer Res; 1999 Oct; 59(20):5286-93. PubMed ID: 10537311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlation of p38 mitogen-activated protein kinase signal transduction pathway to uPA expression in breast cancer].
    Han YC; Zeng XX; Wang R; Zhao Y; Li BL; Song M
    Ai Zheng; 2007 Jan; 26(1):48-53. PubMed ID: 17222367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphatidylinositol 3-kinase and NF-kappaB regulate motility of invasive MDA-MB-231 human breast cancer cells by the secretion of urokinase-type plasminogen activator.
    Sliva D; Rizzo MT; English D
    J Biol Chem; 2002 Feb; 277(5):3150-7. PubMed ID: 11689575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between alphavbeta6 integrin expression, elevated p42/44 kDa MAPK, and plasminogen-dependent matrix degradation in ovarian cancer.
    Ahmed N; Pansino F; Baker M; Rice G; Quinn M
    J Cell Biochem; 2002; 84(4):675-86. PubMed ID: 11835393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer cells with inhibition of p38alpha have decreased MMP-9 activity and exhibit decreased bone metastasis in mice.
    Suarez-Cuervo C; Merrell MA; Watson L; Harris KW; Rosenthal EL; Väänänen HK; Selander KS
    Clin Exp Metastasis; 2004; 21(6):525-33. PubMed ID: 15679050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (-)-Epigallocatechin gallate derivatives reduce the expression of both urokinase plasminogen activator and plasminogen activator inhibitor-1 to inhibit migration, adhesion, and invasion of MDA-MB-231 cells.
    Shin S; Kim MK; Jung W; Chong Y
    Phytother Res; 2018 Oct; 32(10):2086-2096. PubMed ID: 30009577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
    Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
    Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary-type plasminogen activator (uPA) expression and uPA receptor localization are regulated by alpha 3beta 1 integrin in oral keratinocytes.
    Ghosh S; Brown R; Jones JC; Ellerbroek SM; Stack MS
    J Biol Chem; 2000 Aug; 275(31):23869-76. PubMed ID: 10791952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p38 Mitogen-activated protein kinase regulation of endothelial cell migration depends on urokinase plasminogen activator expression.
    Yu J; Bian D; Mahanivong C; Cheng RK; Zhou W; Huang S
    J Biol Chem; 2004 Nov; 279(48):50446-54. PubMed ID: 15371454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor.
    Nicholl SM; Roztocil E; Davies MG
    J Vasc Surg; 2005 Apr; 41(4):672-81. PubMed ID: 15874933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrosine kinase, p56lck-induced cell motility, and urokinase-type plasminogen activator secretion involve activation of epidermal growth factor receptor/extracellular signal regulated kinase pathways.
    Mahabeleshwar GH; Das R; Kundu GC
    J Biol Chem; 2004 Mar; 279(11):9733-42. PubMed ID: 14699120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urokinase-type plasminogen activation in three human breast cancer cell lines correlates with their in vitro invasiveness.
    Holst-Hansen C; Johannessen B; Høyer-Hansen G; Rømer J; Ellis V; Brünner N
    Clin Exp Metastasis; 1996 May; 14(3):297-307. PubMed ID: 8674284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysophosphatidic acid induction of urokinase plasminogen activator secretion requires activation of the p38MAPK pathway.
    Estrella VC; Eder AM; Liu S; Pustilnik TB; Tabassam FH; Claret FX; Gallick GE; Mills GB; Wiener JR
    Int J Oncol; 2007 Aug; 31(2):441-9. PubMed ID: 17611702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system.
    Lee DH; Yang Y; Lee SJ; Kim KY; Koo TH; Shin SM; Song KS; Lee YH; Kim YJ; Lee JJ; Choi I; Lee JH
    Cancer Res; 2003 Aug; 63(15):4648-55. PubMed ID: 12907645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.